PuraPharm Corp. Ltd.'s market cap is currently HK$175.75M. The company's EPS TTM is HK$-0.055; its P/E ratio is ―; PuraPharm Corp. Ltd. is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
